Pelthos Therapeutics Inc. Debt Instrument, Face Amount
Pelthos Therapeutics Inc. (PTHS) had Debt Instrument, Face Amount of $163.00 thousand as of 2025-06-23, per its 10-Q filed 2025-11-13.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2025-11-13
- 2025-06-23: Debt Instrument, Face Amount $163.00K; Debt Instrument, Face Amount as first filed $162.50K.
- 2025-05-08: Debt Instrument, Face Amount $325.00K.
- 2025-03-31: Debt Instrument, Face Amount $325.00K.
- 2025-02-25: Debt Instrument, Face Amount $325.00K.
| Period end | Debt Instrument, Face Amount | Debt Instrument, Face Amount as first filed |
|---|---|---|
| 2025-06-23 | $163.00K 10-Q · filed 2025-11-13 | $162.50K 10-Q · filed 2025-08-13 |
| 2025-05-08 | $325.00K 10-Q · filed 2025-11-13 | |
| 2025-03-31 | $325.00K 10-Q · filed 2025-05-13 | |
| 2025-02-25 | $325.00K 10-Q · filed 2025-11-13 | |
| 2024-07-24 | $750.00K 10-Q · filed 2025-05-13 | |
| 2023-09-30 | $198.13K 10-Q · filed 2025-05-13 | |
| 2023-04-30 | $393.81K 10-Q · filed 2025-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |